This is the first in a series of unique studies looking to evaluate the prevalence of Lichen sclerosus (LS) and its sequelae, with the view to developing more effective management strategies. LS is an enigmatic condition that has resounding implications in management of 20% of individuals who will develop urethral strictures. Stricturing may not be contiguous with the foreskin and can occur distally, as isolated proximal and even panurethral disease. Moreover, LS-associated strictures have high recurrence rates, even after urethroplasty. There is also risk of malignant transformation (2.3-8.4%), however long-term surveillance of patients with LS is uncommon.
INTRODUCTION AND OBJECTIVES:
This is the first in a series of unique studies looking to evaluate the prevalence of Lichen sclerosus (LS) and its sequelae, with the view to developing more effective management strategies. LS is an enigmatic condition that has resounding implications in management of 20% of individuals who will develop urethral strictures. Stricturing may not be contiguous with the foreskin and can occur distally, as isolated proximal and even panurethral disease. Moreover, LS-associated strictures have high recurrence rates, even after urethroplasty. There is also risk of malignant transformation (2.3-8.4%), however long-term surveillance of patients with LS is uncommon.
METHODS: As random genital biopsies could not be undertaken, our study population was men presenting for circumcision. We undertook a retrospective multi-center study of 8 Australian regional centers. Data was collected from all circumcision patients between January 2006 -December 2016, including age, histopathology and urethral stricture or penile cancer treatment. Patients with unavailable medical records were excluded. Histopathological confirmation of LS was the primary outcome. RESULTS: Of 611 circumcision patients included, 48.8% did not have valid pathology sent. Of the remaining 313 patients, 63.6% (n[199) had confirmed LS. Median age at diagnosis was 65 years (IQR 40-77) compared with 22.5 years (IQR 18-41) for patients with normal pathology (p[<0.0001). 78 (24.9%) patients had other histological diagnoses, including acute/chronic inflammation (19.5%), lichen planus (1.9%) and Zoon's balanitis (1.6%). 17.7% (n[34) of patients with LS had urethral strictures, with 26 (13.1%) requiring urethral dilation, 3 (1.5%) urethrotomy and 2 (1.0%) meatotomy. 2 (1.2%) lichen sclerosus patients had histologically confirmed penile cancer, of which one was treated by circumcision (0.5%), the other, radical penectomy (0.5%).
CONCLUSIONS: Our findings show that LS is a highly prevalent disease in circumcision patients. As only a minority of specimens were sent for pathology, this prevalence is likely under-reported. Subsequent or concomitant stricture disease was also high at almost 20%. Current practices in attaining tissue diagnosis and ongoing surveillance may be insufficient, subjecting patients to serious and possibly preventable complications. Further research should prospectively evaluate all circumcision specimens and include biopsy of men presenting with idiopathic urethral stricture disease to ascertain the incidence of silent LS.
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MP53-08 EARLY AND LATE EFFICACY ON WOUND HEALING OF SILVER NANOPARTICLES GEL (PEONILÒ) IN MALES UNDERWENT CIRCUMCISION
Matteo Balzarro*, Emanuele Rubilotta, Anna Marcer, Antonio Soldano, Nicol o Trabacchin, Verona, Italy; Vito Mancini, Foggia, Italy; Filippo Migliorini, Verona, Italy; Antonio Luigi Pastore, Antonio Carbone, Latina, Italy; Luigi Cormio, Giuseppe Carrieri, Foggia, Italy; Walter Artibani, Verona, Italy INTRODUCTION AND OBJECTIVES: Silver nanoparticles (AgNPs) have bactericidal activity promoting wound healing through facilitated anti-inflammatory action, accelerating of the wound-healing process. This improves the tensile properties of the repaired skin. Aim of this study was to evaluate the early and late clinical safety, and efficacy of AgNPs in wound healing after circumcision.
METHODS: This multicenter randomized prospective ongoing observational study compared the medication with gel containing AgNPs, titanium dioxide, hyaluronic acid, and aloe vera (PeonilÒ) vs topical gentamicin cream (TGC) in males underwent circumcision. From January to September 2018 males were randomized in Group A (AgNPs) and control Group B (TGC). Exclusion criteria were: corticosteroids and/or other immunosuppressive therapies, diabetes, conditions causing immunosuppression. After circumcision all pts had a single prophylactic application of TGC. Medication was carried out 3 times a day, for 10 days. Follow-up included clinical objective evaluation at 10 and 30 days, and the following healing validated scales:
Southampton Scoring System Stony Brook Scar Evaluation Scale Good healing was considered at Southampton Scoring System the grade < 1 (normal healing or with mild bruising or erythema), and at the Stony Brook Scar Evaluation Scale a total score of 0 points.
Statistical analysis was performed by Chi-square and Fisher exact test.
RESULTS: In the study 186 patients were enrolled: Group A (92 pts) and B (94 pts) with similar demographic characteristics. Mean age was 34.2 years, standard deviation AE18.4. Table 1 reports wound healing in the two groups. At 10 and 30 days we found not statistically significant difference in the groups. No major complications occurred, and none patient needed surgical wound revision. However, in Group B 7.4% of the males (7/94), at the 10 days follow-up, needed additional antibiotic therapy due to pus discharge associated to a < 1cm diastasis.
CONCLUSIONS: Topical use of AgNPs after circumcision was safe and effective with non-inferiority wound healing rate. The antibacterial efficacy of AgNPs was useful in avoiding the use of antibiotics.
